Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J ROBERTS

Showing results (801-810 of 5,897) with videos related to

Pageof 590
Sort By:
Oral Surgery, Oral Medicine, and Oral Pathology|March 1, 1991
Immediate and delayed direct pulp capping with the use of a new visible light-cured calcium hydroxide preparationT R Pitt Ford, G J Roberts
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|January 12, 2000
Gorham's disease: a case (including dental presentation) of vanishing bone diseaseI Holroyd, M Dillon, G J Roberts
Arzneimittel-Forschung|January 1, 1976
Pharmacological properties of thiazolinobutazone (LAS 11 871). III. General pharmacology, ulcerogenic effects and acute toxicityM Colombo, M Márquez, D J Roberts
American Journal of Mental Retardation : AJMR|August 18, 1999
Behavior states: now you see them, now you don'tO C Mudford, J Hogg, J Roberts
Development (Cambridge, England)|February 7, 2002
Tail gut endoderm and gut/genitourinary/tail development: a new tissue-specific role for Hoxa13Pascal de Santa Barbara, Drucilla J Roberts
Anaesthesia and Intensive Care|June 22, 2002
Career choice influences in Australian anaesthetistsL J Roberts, D C S Khursandi
American Journal of Veterinary Research|July 1, 1975
Certain features of erythrocytes of normal and glutathione-deficient sheepN S Agar, J Roberts, J Sheedy
The Journal of Rheumatology|July 1, 1989
Interleukin 2 and interleukin 2 inhibitors in human serum and synovial fluid. II. Mitogenic stimulation, interleukin 2 production and interleukin 2 receptor expression in rheumatoid arthritis, psoriatic arthritis and Reiter's syndromeM D Smith, P J Roberts-Thomson
British Medical Journal|October 14, 1978
Decreased first-pass metabolism of labetalol in chronic liver diseaseM Homeida, L Jackson, C J Roberts
CNS & Neurological Disorders Drug Targets|May 30, 2015
Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use DisordersDouglas J Roberts-Wolfe, Peter W Kalivas
Pageof 590

Showing results (801-810 of 5,897) with videos related to

Sort By:
Pageof 590
Oral Surgery, Oral Medicine, and Oral Pathology|March 1, 1991
Immediate and delayed direct pulp capping with the use of a new visible light-cured calcium hydroxide preparationT R Pitt Ford, G J Roberts
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|January 12, 2000
Gorham's disease: a case (including dental presentation) of vanishing bone diseaseI Holroyd, M Dillon, G J Roberts
Arzneimittel-Forschung|January 1, 1976
Pharmacological properties of thiazolinobutazone (LAS 11 871). III. General pharmacology, ulcerogenic effects and acute toxicityM Colombo, M Márquez, D J Roberts
American Journal of Mental Retardation : AJMR|August 18, 1999
Behavior states: now you see them, now you don'tO C Mudford, J Hogg, J Roberts
Development (Cambridge, England)|February 7, 2002
Tail gut endoderm and gut/genitourinary/tail development: a new tissue-specific role for Hoxa13Pascal de Santa Barbara, Drucilla J Roberts
Anaesthesia and Intensive Care|June 22, 2002
Career choice influences in Australian anaesthetistsL J Roberts, D C S Khursandi
American Journal of Veterinary Research|July 1, 1975
Certain features of erythrocytes of normal and glutathione-deficient sheepN S Agar, J Roberts, J Sheedy
The Journal of Rheumatology|July 1, 1989
Interleukin 2 and interleukin 2 inhibitors in human serum and synovial fluid. II. Mitogenic stimulation, interleukin 2 production and interleukin 2 receptor expression in rheumatoid arthritis, psoriatic arthritis and Reiter's syndromeM D Smith, P J Roberts-Thomson
British Medical Journal|October 14, 1978
Decreased first-pass metabolism of labetalol in chronic liver diseaseM Homeida, L Jackson, C J Roberts
CNS & Neurological Disorders Drug Targets|May 30, 2015
Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use DisordersDouglas J Roberts-Wolfe, Peter W Kalivas
Pageof 590